stage iia pancreatic cancer

Showing 1 - 16 of 16

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer Trial in United

Active, not recruiting
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Fairfield, Connecticut
  • +8 more
Oct 31, 2022

Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City

Recruiting
  • Metastatic Pancreatic Carcinoma
  • +6 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Oct 31, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Colon Carcinoma Metastatic in the Liver, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Atlanta, Rochester

Active, not recruiting
  • Colon Carcinoma Metastatic in the Liver
  • +13 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +3 more
  • Atlanta, Georgia
  • +3 more
Dec 15, 2021

Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in Richmond (drug, radiation, other)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Oct 20, 2021

Stage I Adult Liver Cancer, Stage I Colorectal Cancer, Stage IA Gastric Cancer Trial in Duarte (Computer-Assisted Intervention,

Completed
  • Stage I Adult Liver Cancer
  • +30 more
  • Computer-Assisted Intervention
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 5, 2021

Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer Trial in Omaha (procedure, drug, other,

Completed
  • Pancreatic Adenocarcinoma
  • +8 more
  • 4-Dimensional Computed Tomography
  • +8 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Feb 24, 2020

Pancreatic Adenocarcinoma, Poorly Differentiated Malignant Tumor, Resectable Pancreatic Cancer Trial in Cleveland (Irinotecan

Terminated
  • Pancreatic Adenocarcinoma
  • +8 more
  • Irinotecan Hydrochloride
  • +4 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jun 13, 2018

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +7 more
  • Alhambra, California
  • +16 more
Jan 5, 2018

Patient Derived Cancer Cell Lines in Identifying Molecular

Withdrawn
  • Pancreatic Ductal Adenocarcinoma
  • +6 more
  • Laboratory Biomarker Analysis
  • Cytology Specimen Collection Procedure
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Sep 5, 2017

Adenocarcinoma of the Pancreas, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in Seattle (drug, radiation,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • gemcitabine hydrochloride
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 13, 2017

Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial (metformin HCl, pharmacological study)

Withdrawn
  • Stage IA Pancreatic Cancer
  • +3 more
  • metformin hydrochloride
  • pharmacological study
  • (no location specified)
Jul 14, 2015

Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Duarte (Psychosocial Assessment

Completed
  • Stage IIA Pancreatic Cancer
  • +3 more
  • Psychosocial Assessment and Care
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jun 1, 2015

Intraductal Papillary Mucinous Tumor of the Pancreas, Recurrent Pancreatic Cancer, Stage IA Pancreatic Cancer Trial in Orange

Terminated
  • Intraductal Papillary Mucinous Neoplasm of the Pancreas
  • +6 more
  • erlotinib hydrochloride
  • +6 more
  • Orange, California
    University of California Medical Center At Irvine-Orange Campus
Oct 7, 2014

Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Boston (biological, drug,

Completed
  • Stage IA Pancreatic Cancer
  • +3 more
  • cetuximab
  • +5 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
May 6, 2014

Adenocarcinoma of the Pancreas, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in United States (drug, other,

Terminated
  • Adenocarcinoma of the Pancreas
  • +4 more
  • gamma-secretase/Notch signalling pathway inhibitor RO4929097
  • +4 more
  • Beverly Hills, California
  • +5 more
Sep 27, 2013